SCHEMBL9203367

SCHEMBL9203367

CCCCc1cn(C2CCC2=O)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)nc1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 15/20 0.58
AGTR2 P50052 13/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9201908 0.95 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9208806 0.95 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9206307 0.95 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9286301 0.95 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9278756 0.93 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9277026 0.90 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL7675463 0.90 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL9277198 0.90 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9209613 0.89 AGTR1 (0.71) AGTR1AGTR2
SCHEMBL7679989 0.89 AGTR1 (0.62) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0664803-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1995-08-02 EP disclosed
WO-1994008989-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1994-04-28 WO disclosed